Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Signal Transduct Target Ther ; 6(1): 418, 2021 12 10.
Artigo em Inglês | MEDLINE | ID: mdl-34893580

RESUMO

The systemic processes involved in the manifestation of life-threatening COVID-19 and in disease recovery are still incompletely understood, despite investigations focusing on the dysregulation of immune responses after SARS-CoV-2 infection. To define hallmarks of severe COVID-19 in acute disease (n = 58) and in disease recovery in convalescent patients (n = 28) from Hannover Medical School, we used flow cytometry and proteomics data with unsupervised clustering analyses. In our observational study, we combined analyses of immune cells and cytokine/chemokine networks with endothelial activation and injury. ICU patients displayed an altered immune signature with prolonged lymphopenia but the expansion of granulocytes and plasmablasts along with activated and terminally differentiated T and NK cells and high levels of SARS-CoV-2-specific antibodies. The core signature of seven plasma proteins revealed a highly inflammatory microenvironment in addition to endothelial injury in severe COVID-19. Changes within this signature were associated with either disease progression or recovery. In summary, our data suggest that besides a strong inflammatory response, severe COVID-19 is driven by endothelial activation and barrier disruption, whereby recovery depends on the regeneration of the endothelial integrity.


Assuntos
Anticorpos Antivirais/sangue , Proteínas Sanguíneas/metabolismo , COVID-19/diagnóstico , Síndrome da Liberação de Citocina/diagnóstico , Endotélio Vascular/virologia , Linfopenia/diagnóstico , SARS-CoV-2/patogenicidade , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , COVID-19/imunologia , COVID-19/mortalidade , COVID-19/virologia , Quimiocina CXCL10/sangue , Quimiocina CXCL9/sangue , Análise por Conglomerados , Convalescença , Síndrome da Liberação de Citocina/imunologia , Síndrome da Liberação de Citocina/mortalidade , Síndrome da Liberação de Citocina/virologia , Progressão da Doença , Endotélio Vascular/imunologia , Granulócitos/imunologia , Granulócitos/virologia , Fatores de Crescimento de Células Hematopoéticas/sangue , Fator de Crescimento de Hepatócito/sangue , Humanos , Unidades de Terapia Intensiva , Subunidade p40 da Interleucina-12/sangue , Interleucina-6/sangue , Interleucina-8/sangue , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/virologia , Lectinas Tipo C/sangue , Linfopenia/imunologia , Linfopenia/mortalidade , Linfopenia/virologia , Plasmócitos/imunologia , Plasmócitos/virologia , Análise de Sobrevida , Linfócitos T/imunologia , Linfócitos T/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...